Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis-Reference-Cited by-同舟云学术

Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

Author:

Peyro Saint Paul Laure¹,Debruyne Danièle²,Bernard Delphine³,Mock Donald M.⁴,Defer Gilles L.⁵⁶

Affiliation:

1. Clinical Research, Centre Hospitalier Universitaire de Caen, Caen, France

2. Pharmacology, Centre Hospitalier Universitaire de Caen, Caen, France

3. MedDay Pharmaceuticals, ICM-Brain and Spine Institute-IPEPs, Groupe Hospitalier Pitié Salpêtrière, Paris, France

4. Department of Biochemistry & Molecular Biology and Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA

5. Neurology, Centre Hospitalier Universitaire de Caen, Caen, France

6. INSERM U 919, GIP Cyceron, Caen, France

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

Reference114 articles.

1. Multiple Sclerosis International Federation (MSIF). Atlas of MS 2013. Mapping multiple sclerosis around the world; 2013.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献